GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kimia Farma Tbk PT KAEF.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

352

+0.57%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 9.22trn

FY2016FY2025

Net income

−IDR 334.96bn

FY2016FY2025

Free cash flow

IDR 104.46bn

FY2016FY2025

Shareholders' equity

IDR 2.66trn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueIDR 9.22trnIDR 9.94trnIDR 9.97trnIDR 9.23trnIDR 12.86trnIDR 10.01trnIDR 9.40trnIDR 7.45trnIDR 6.13trnIDR 5.81trn
Gross profitIDR 2.68trnIDR 2.95trnIDR 2.78trnIDR 3.52trnIDR 4.40trnIDR 3.66trnIDR 3.50trnIDR 2.78trnIDR 2.20trnIDR 1.86trn
Research and developmentIDR 41.13bnIDR 31.62bnIDR 108.10bnIDR 46.37bnIDR 41.35bnIDR 15.53bnIDR 15.32bnIDR 18.07bnIDR 37.43bnIDR 24.45bn
Operating income−IDR 248.17bn−IDR 810.72bn−IDR 1.54trnIDR 497.05bnIDR 985.64bnIDR 669.74bnIDR 501.66bnIDR 765.02bnIDR 535.66bnIDR 442.82bn
Net income−IDR 334.96bn−IDR 842.27bn−IDR 1.49trn−IDR 190.47bnIDR 302.27bnIDR 17.64bn−IDR 12.72bnIDR 415.90bnIDR 326.79bnIDR 267.41bn
Diluted earnings per share-60.17-147.40-267.48-34.2954.423.18-2.2974.8858.8448.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsIDR 14.18trnIDR 14.97trnIDR 17.59trnIDR 20.35trnIDR 17.76trnIDR 17.56trnIDR 18.35trnIDR 9.46trnIDR 6.10trnIDR 4.61trn
Cash and short-term investmentsIDR 653.58bnIDR 437.59bnIDR 832.67bnIDR 2.19trnIDR 748.48bnIDR 1.25trnIDR 1.36trnIDR 1.96trnIDR 989.64bnIDR 647.68bn
Total liabilitiesIDR 11.67trnIDR 11.54trnIDR 11.19trnIDR 11.01trnIDR 10.53trnIDR 10.46trnIDR 10.94trnIDR 6.10trnIDR 3.52trnIDR 2.34trn
DebtIDR 6.98trnIDR 7.25trnIDR 7.73trnIDR 8.11trnIDR 8.02trnIDR 7.76trnIDR 8.30trnIDR 4.87trnIDR 2.25trnIDR 822.40bn
Shareholders' equityIDR 2.66trnIDR 2.29trnIDR 5.89trnIDR 7.14trnIDR 7.14trnIDR 6.99trnIDR 7.24trnIDR 3.20trnIDR 2.51trnIDR 2.22trn
Shares outstanding5,567m5,714m5,554m5,554m5,554m5,554m5,554m5,554m5,554m5,554m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsIDR 236.75bnIDR 153.62bn−IDR 364.58bnIDR 403.34bn−IDR 223.92bnIDR 1.02trn−IDR 1.85trnIDR 195.75bnIDR 32.64bnIDR 213.43bn
Capital spending−IDR 132.29bn−IDR 175.83bn−IDR 867.78bn−IDR 596.61bn−IDR 659.25bn−IDR 548.57bn−IDR 778.87bn−IDR 1.05trn−IDR 753.31bn−IDR 371.72bn
Free cash flowIDR 104.46bn−IDR 22.22bn−IDR 1.23trn−IDR 193.27bn−IDR 883.18bnIDR 470.40bn−IDR 2.63trn−IDR 855.31bn−IDR 720.67bn−IDR 158.29bn
Dividends paid—−IDR 78.6m—−IDR 9.02bn−IDR 702.2m−IDR 702.2m−IDR 83.20bn−IDR 98.08bn−IDR 53.49bn−IDR 49.77bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueIDR 2.67trnIDR 2.03trnIDR 2.22trnIDR 2.64trnIDR 2.20trnIDR 2.17trnIDR 2.07trnIDR 2.65trn
Gross profitIDR 934.89bnIDR 784.50bnIDR 462.82bnIDR 794.72bnIDR 757.88bnIDR 742.67bnIDR 592.86bnIDR 773.93bn
Operating incomeIDR 80.09bnIDR 46.99bn−IDR 286.13bnIDR 20.39bnIDR 86.06bn−IDR 4.43bn−IDR 613.22bn−IDR 136.10bn
Net income−IDR 64.12bnIDR 74.45bn−IDR 155.23bn−IDR 84.72bnIDR 7.16bn−IDR 102.18bn−IDR 420.44bn−IDR 195.05bn
Diluted earnings per share-11.5213.37-27.89-15.221.29-18.36-73.58-34.13
Cash from operations−IDR 180.20bnIDR 87.10bnIDR 119.74bnIDR 191.81bnIDR 54.66bn−IDR 129.47bnIDR 266.53bn−IDR 68.77bn
Capital spending−IDR 4.77bn−IDR 15.86bn−IDR 12.77bn−IDR 15.30bn−IDR 46.63bn−IDR 57.97bn−IDR 31.39bn−IDR 76.13bn
Free cash flow−IDR 184.98bnIDR 71.24bnIDR 106.97bnIDR 176.51bnIDR 8.04bn−IDR 187.43bnIDR 235.14bn−IDR 144.90bn
Total assetsIDR 14.70trnIDR 14.36trnIDR 14.18trnIDR 14.91trnIDR 14.97trnIDR 15.03trnIDR 14.97trnIDR 16.80trn
Cash and short-term investmentsIDR 445.47bnIDR 586.07bnIDR 653.58bnIDR 621.05bnIDR 464.29bnIDR 251.23bnIDR 437.59bnIDR 505.11bn
DebtIDR 6.99trnIDR 6.72trnIDR 7.02trnIDR 7.18trnIDR 7.17trnIDR 7.25trnIDR 7.25trnIDR 7.56trn
Shareholders' equityIDR 2.90trnIDR 2.73trnIDR 2.66trnIDR 3.02trnIDR 3.11trnIDR 2.35trnIDR 2.29trnIDR 5.33trn

Financial ratios

Data as of 27 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin29.1%29.6%27.9%38.1%34.2%36.5%
Operating margin-2.7%-8.2%-15.5%5.4%7.7%6.7%
Net margin-3.6%-8.5%-14.9%-2.1%2.4%0.2%
Return on equity-12.6%-36.7%-25.2%-2.7%4.2%0.3%
Return on assets-2.4%-5.6%-8.4%-0.9%1.7%0.1%
Free cash flow yield15.2%13.2%20.8%41.3%18.0%64.7%
Revenue growth-7.2%-0.3%7.9%-28.2%28.5%6.4%
Earnings growth-60.2%-43.3%679.9%-163.0%1613.7%-238.6%
Current ratio0.56x0.49x0.63x0.94x1.05x0.90x
Debt to equity2.61x3.13x1.30x1.13x1.12x1.11x
Equity ratio18.8%15.3%33.5%35.1%40.2%39.8%
Interest coverage-0.42x-1.90x-2.48x0.95x1.62x1.12x
R&D as a share of sales0.4%0.3%1.1%0.5%0.3%0.2%
Buybacks as a share of market value2.6%-2.9%0.0%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.0%-1.6%6.6%
Net income20.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.4%31.1%32.6%33.6%
Operating margin-5.5%-5.5%-0.7%2.3%
Net margin-6.1%-7.4%-4.1%-1.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-8.6-4.1-5.4-31.644.6—-545.634.745.957.1
Price to sales0.30.30.80.71.12.40.71.92.52.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 23 May 2022.

FY2022FY2021FY2019FY2018FY2017FY2016FY2015FY2014
Paid in the year16.3271.2714.9817.669.638.9618.4499.657

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.